IBDEI081 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3611,0)
 ;;=700.^^31^317^7
 ;;^UTILITY(U,$J,358.3,3611,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3611,1,2,0)
 ;;=2^700.
 ;;^UTILITY(U,$J,358.3,3611,1,5,0)
 ;;=5^Corns And Callosities
 ;;^UTILITY(U,$J,358.3,3611,2)
 ;;=^18351
 ;;^UTILITY(U,$J,358.3,3612,0)
 ;;=709.09^^31^317^2
 ;;^UTILITY(U,$J,358.3,3612,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3612,1,2,0)
 ;;=2^709.09
 ;;^UTILITY(U,$J,358.3,3612,1,5,0)
 ;;=5^Cafe au lait spot
 ;;^UTILITY(U,$J,358.3,3612,2)
 ;;=^303313
 ;;^UTILITY(U,$J,358.3,3613,0)
 ;;=709.3^^31^317^3
 ;;^UTILITY(U,$J,358.3,3613,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3613,1,2,0)
 ;;=2^709.3
 ;;^UTILITY(U,$J,358.3,3613,1,5,0)
 ;;=5^Calcinosis,Skin
 ;;^UTILITY(U,$J,358.3,3613,2)
 ;;=^31460
 ;;^UTILITY(U,$J,358.3,3614,0)
 ;;=380.00^^31^317^4
 ;;^UTILITY(U,$J,358.3,3614,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3614,1,2,0)
 ;;=2^380.00
 ;;^UTILITY(U,$J,358.3,3614,1,5,0)
 ;;=5^Chondrodermatitis Nodularis Helicis
 ;;^UTILITY(U,$J,358.3,3614,2)
 ;;=^269337
 ;;^UTILITY(U,$J,358.3,3615,0)
 ;;=706.2^^31^317^8
 ;;^UTILITY(U,$J,358.3,3615,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3615,1,2,0)
 ;;=2^706.2
 ;;^UTILITY(U,$J,358.3,3615,1,5,0)
 ;;=5^Cyst,Epidermal
 ;;^UTILITY(U,$J,358.3,3615,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,3616,0)
 ;;=078.11^^31^317^6
 ;;^UTILITY(U,$J,358.3,3616,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3616,1,2,0)
 ;;=2^078.11
 ;;^UTILITY(U,$J,358.3,3616,1,5,0)
 ;;=5^Condyloma NOS
 ;;^UTILITY(U,$J,358.3,3616,2)
 ;;=^295788
 ;;^UTILITY(U,$J,358.3,3617,0)
 ;;=710.1^^31^317^1
 ;;^UTILITY(U,$J,358.3,3617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3617,1,2,0)
 ;;=2^710.1
 ;;^UTILITY(U,$J,358.3,3617,1,5,0)
 ;;=5^CRST Syndrome
 ;;^UTILITY(U,$J,358.3,3617,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,3618,0)
 ;;=078.11^^31^317^5
 ;;^UTILITY(U,$J,358.3,3618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3618,1,2,0)
 ;;=2^078.11
 ;;^UTILITY(U,$J,358.3,3618,1,5,0)
 ;;=5^Condyloma Accuminatum
 ;;^UTILITY(U,$J,358.3,3618,2)
 ;;=^295788
 ;;^UTILITY(U,$J,358.3,3619,0)
 ;;=216.8^^31^318^1
 ;;^UTILITY(U,$J,358.3,3619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3619,1,2,0)
 ;;=2^216.8
 ;;^UTILITY(U,$J,358.3,3619,1,5,0)
 ;;=5^Dermatofibroma
 ;;^UTILITY(U,$J,358.3,3619,2)
 ;;=^267637
 ;;^UTILITY(U,$J,358.3,3620,0)
 ;;=710.3^^31^318^3
 ;;^UTILITY(U,$J,358.3,3620,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3620,1,2,0)
 ;;=2^710.3
 ;;^UTILITY(U,$J,358.3,3620,1,5,0)
 ;;=5^Dermatomyositis
 ;;^UTILITY(U,$J,358.3,3620,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,3621,0)
 ;;=709.00^^31^318^5
 ;;^UTILITY(U,$J,358.3,3621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3621,1,2,0)
 ;;=2^709.00
 ;;^UTILITY(U,$J,358.3,3621,1,5,0)
 ;;=5^Dyschromia
 ;;^UTILITY(U,$J,358.3,3621,2)
 ;;=^37473
 ;;^UTILITY(U,$J,358.3,3622,0)
 ;;=709.9^^31^318^4
 ;;^UTILITY(U,$J,358.3,3622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3622,1,2,0)
 ;;=2^709.9
 ;;^UTILITY(U,$J,358.3,3622,1,5,0)
 ;;=5^Dermatosis NOS
 ;;^UTILITY(U,$J,358.3,3622,2)
 ;;=^111083
 ;;^UTILITY(U,$J,358.3,3623,0)
 ;;=708.3^^31^318^2
 ;;^UTILITY(U,$J,358.3,3623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3623,1,2,0)
 ;;=2^708.3
 ;;^UTILITY(U,$J,358.3,3623,1,5,0)
 ;;=5^Dermatographia
 ;;^UTILITY(U,$J,358.3,3623,2)
 ;;=^265291
 ;;^UTILITY(U,$J,358.3,3624,0)
 ;;=705.81^^31^318^6
 ;;^UTILITY(U,$J,358.3,3624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3624,1,2,0)
 ;;=2^705.81
 ;;^UTILITY(U,$J,358.3,3624,1,5,0)
 ;;=5^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,3624,2)
 ;;=^96545
 ;;^UTILITY(U,$J,358.3,3625,0)
 ;;=459.89^^31^319^1
 ;;^UTILITY(U,$J,358.3,3625,1,0)
 ;;=^358.31IA^5^2
